Bristol-Myers Squibb to close Irish plant


Bristol-Myers Squibb (BMS) is to close its manufacturing plant in Cruiserath, Ireland, with the loss of 130 jobs by the end of 2015. A further 30 positions will be cut at the nearby plant in Swords as one of several operating units on that site is also shuttered.

BMS tied the closures to ‘changing market demand’ for its products, along with efforts to optimise its manufacturing network. The remaining 320 employees at the Swords plant will continue to manufacture bulk pharmaceuticals.

Susan Hynes, BMS’s general manager of active pharmaceutical ingredient operations Ireland, said in a statement that ‘the company is working to explore potential future uses of the Cruiserath facility and will endeavour to minimise job losses in Ireland’.


Related Content

BMS sells OTC drugs for $482m

14 February 2013 Business

news image

Bristol-Myers Squibb will offload rights to a range of over-the-counter products to Reckitt Benckiser

Amylin headquarters to close with further job losses

4 April 2013 Business

news image

Bristol-Myers Squibb plans to shutter the San Diego, US, site following last year’s merger

Most Read

Mystery of coloured water droplets that chase and repel each other solved

19 March 2015 Research

news image

Discovery could herald sprays that hoover up dirt and keep solar panels clean

Simple cooking changes make healthier rice

23 March 2015 Research

news image

Adding oil to water, cooling and reheating rice makes fibre-like resistant starch, reducing calories

Most Commented

Worrying molecule found in bottled water

9 September 2013 Research

news image

Analysis finds a new endocrine disrupting chemical in bottled water

Impatient chemistry

28 February 2014 Last Retort

news image

Is the pressure to publish making chemists cut corners?